Meeting Report – Joint HTA in the European Union

If everything goes according to plan, member states of the European Union will in future use a common methodology to decide whether a new medicine or medical device is clinically effective, relative to certain benchmarks, and therefore be considered for reimbursement. This is the scenario envisioned by the European Commission under a proposed Regulation on Health Technology Assessment, which was unveiled earlier this year.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Netherlands